The role of recombinant activated factor VII in neurosurgical and neurocritical patients

被引:0
|
作者
Rama-Maceiras, P. [1 ]
Ingelmo-Ingelmo, I. [2 ]
Fabregas-Julia, N. [3 ]
Hernandez-Palazon, J. [4 ]
机构
[1] Complejo Hosp Univ A Coruna, Serv Anestesiol & Reanimac, La Coruna 15006, Spain
[2] Hosp Univ Ramon & Cajal, Madrid, Spain
[3] Univ Barcelona, Hosp Clin Barcelona, Murcia, Spain
[4] Hosp Univ Virgen de la Arrixaca, Murcia, Spain
来源
NEUROCIRUGIA | 2011年 / 22卷 / 03期
关键词
Blood coagulation disorders; Intracranial haemorrhages; Recombinant FVIIa; Critical care; CENTRAL-NERVOUS-SYSTEM; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; UNEXPECTED POSTHEMORRHAGIC HYDROCEPHALUS; INTERNATIONAL NORMALIZED RATIO; NON-HEMOPHILIAC PATIENTS; TRAUMATIC BRAIN-INJURY; INTRAVENTRICULAR HEMORRHAGE; INTRACRANIAL HEMORRHAGE; INTRACTABLE HEMORRHAGE; FACTOR VLLA;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Central nervous system haemorrhage is a severe pathology, as a small amount of bleeding inside the brain can result in devastating consequences. Haemostatic agents might decrease the consequences of intracranial bleeding, whichever spontaneous, traumatic, or anticoagulation treatment etiology. Proacogulant recombinant activated factor VII (rFVIIa) has been given after central nervous system bleeding, with an off-label indication. In this update, we go over the drug mechanism of action, its role in the treatment of central nervous system haemorrhage and the published evidences regarding this subject. We carried out a literature review concerning the treatment with rFVIIa in central nervous system haemorrhage, neurocritical pathologies and neurosurgical procedures, searching in MEDLINE and in clinical trials registry: http://clinicaltrials.gov (last review September 2010), as well as performing a manual analysis of collected articles, looking for aditional references. The results of randomized clinical trials do not support the systematic administration of rFVIIa for spontaneous intracranial cerebral haemorrhage. In other central nervous system related haemorrhages, the current available data consist on retrospective studies, expert opinion or isolated case reports.
引用
收藏
页码:209 / 223
页数:15
相关论文
共 50 条
  • [1] Use of recombinant activated factor VII in neurosurgical and neurocritical patients
    Ingelmo Ingelmo, I.
    Rama-Maceiras, P.
    Fabregas Julia, N.
    Hernandez Palazon, J.
    [J]. REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2009, 56 (06): : 339 - 342
  • [2] The emerging role of recombinant-activated factor VII in neurocritical care
    Matthew E. Fewel
    Paul Park
    [J]. Neurocritical Care, 2004, 1 : 19 - 29
  • [3] The emerging role of recombinant-activated Factor VII in neurocritical care
    Fewel, ME
    Park, P
    [J]. NEUROCRITICAL CARE, 2004, 1 (01) : 19 - 29
  • [4] Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients
    Park, P
    Fewel, ME
    Garton, HJ
    Thompson, BG
    Hoff, JT
    [J]. NEUROSURGERY, 2003, 53 (01) : 34 - 38
  • [5] Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients
    Fewel, ME
    Park, P
    Garton, HJL
    Thompson, BG
    Hoff, JT
    [J]. NEUROSURGERY, 2003, 53 (02) : 515 - 516
  • [6] Evaluation of recombinant activated factor VII use in critically ill neurosurgical patients
    Garbovsky, Lyudmila A.
    Brophy, Gretchen M.
    [J]. CRITICAL CARE MEDICINE, 2007, 35 (12) : A217 - A217
  • [7] RECOMBINANT ACTIVATED FACTOR VII IN CRITICALLY ILL NEUROSURGICAL PATIENTS WITH ACUTE INTRACRANIAL HEMORRHAGE
    Brophy, Gretchen
    Taylor, Perry
    Smith, Amber
    Oberlander, Eric
    Graham, Scott
    Robles, Jamie R.
    [J]. JOURNAL OF NEUROTRAUMA, 2009, 26 (08) : A24 - A24
  • [8] Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients - Comments
    Dempsey, RJ
    Findlay, JM
    Lawton, MT
    [J]. NEUROSURGERY, 2003, 53 (01) : 38 - 39
  • [9] The role of recombinant-activated factor VII in bleeding trauma patients
    Dutton, Richard P.
    Conti, Bianca M.
    [J]. CURRENT OPINION IN ANESTHESIOLOGY, 2009, 22 (02) : 299 - 304
  • [10] Standardization of factor VII/activated factor VII measurement in plasma of patients treated with recombinant factor activated VII
    Goudemand, J
    Caron, C
    Dreyfus, M
    Sié, P
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (05) : 505 - 511